CroíValve is developing a safe, effective and minimally invasive device to treat Tricuspid Regurgitation,to reduce mortality and improve quality of life.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Dublin, Ireland
  • Currency EUR
  • Founded October 2016
  • Employees 4
  • Incorporation Type LLC
  • Website croivalve.com

Company Summary

Led by an experienced team, CroíValve is developing a transcatheter device to treat Tricuspid Regurgitation; a progressive, debilitating disease affecting 550,000 patients annually. This is a significant unmet clinical need and a €3bn market opportunity.The CroiValve device offers improved patient outcomes and reduced healthcare costs. There is a well-defined route to market, and significant early acquisition predicates in the range $200-450M.